Eidolon Therapeutics

Eidolon Therapeutics is at the forefront of reshaping tumour immunity with precision and purpose, driving innovation in the hospitals and healthcare sector. Located in London, Eidolon Therapeutics pioneers a novel form of immunotherapy, leveraging engineered immune regulators derived from microbial proteins to eliminate cancer cells. Their groundbreaking approach is setting new standards in the industry. The primary address for Eidolon Therapeutics is 237 Fulham Road, London, SW3 6JB, GB.

Eidolon Therapeutics is dedicated to advancing healthcare solutions through cutting-edge research and development. By focusing on reshaping tumour immunity, Eidolon Therapeutics is committed to making a significant impact on patient outcomes. Their innovative approach is poised to revolutionize cancer treatment and enhance the overall quality of life for individuals affected by the disease.

Eidolon Therapeutics is continuously working to expand its reach and capabilities, contributing to the advancement of medical science. The team at Eidolon Therapeutics is dedicated to excellence and innovation, ensuring they remain a leader in the healthcare industry. We encourage the management team to enhance this profile with a customized and exclusive company showcase and product listing on our platform.